A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

  title={A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.},
  author={Stephen V. Faraone and Stephen J. Glatt},
  journal={The Journal of clinical psychiatry},
  volume={71 6},
  • S. Faraone, S. Glatt
  • Published 1 June 2010
  • Medicine, Psychology
  • The Journal of clinical psychiatry
OBJECTIVES Medications used to treat attention-deficit/hyperactivity disorder (ADHD) in adults have been well researched, but comparisons among drugs are hindered by the absence of direct comparative trials. Our objectives were to (1) estimate the effect size of the medications used to treat adult ADHD, (2) determine if differences in the designs of studies confound comparisons of medication efficacy, (3) quantify the evidence for differences in effect sizes among medications, and (4) see if… 

Figures and Tables from this paper

Psychopharmacology and psychotherapy for the treatment of adults with ADHD—a systematic review of available meta-analyses
The available meta-analytic literature does not cover questions of essential clinical relevance for adults with ADHD, and results suggest that stimulants are effective in decreasing ADHD symptoms on a short-term basis with a medium to large effect size (ES).
Pharmacological treatment of adult ADHD
Effect sizes from the most recent studies are calculated and they are almost identical with prior estimates, and in terms of Cohen-d typically indicate medium-to-high effect sizes for the pharmacotherapy of adult ADHD.
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
A systematic review of randomised clinical trials (RCTs) for methylphenidate treatment for children and adolescents with ADHD demonstrated no increase in serious adverse events, but a high proportion of participants suffered a range of non-serious adverse events.
Long-Term Efficacy of Psychosocial Treatments for Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
The results indicate that the post-treatment gains reported in previous reviews are sustained for at least 12 months, and psychological interventions are a highly valuable and stable clinical tool for the treatment of core symptoms and global functioning in adults with ADHD.
Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis
Results indicate that effects of MPH on executive functions are independent of age in children and adults with ADHD, however, adolescent studies are lacking and needed to conclude a lack of an age-dependency across the lifespan.
Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults
There are adequate data demonstrating short-term efficacy and safety of medication in ADHD during adulthood but long-term studies are lacking, particularly in view of concerns regarding cardiovascular adverse events.
A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
This review focuses on the pathophysiology, etiology, and treatment of ADHD and details the adverse effects and drug interaction profiles of the drugs used to treat it.


Comparing the efficacy of medications for ADHD using meta-analysis.
OBJECTIVE Medications used to treat attention-deficit/hyperactivity disorder (ADHD) have been well researched, but comparisons among drugs are hindered by the absence of direct comparative trials.
Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder
Strong support is found for the assertion that MPH is efficacious for treating adult ADHD and provides further assurance to clinicians that the diagnosis of ADHD can be validly applied in adulthood.
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
The results suggest a therapeutic role for bupropion in the armamentarium of agents for ADHD in adults, while further validating the continuity of pharmacological responsivity of ADHD across the lifespan.
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
Clonidine may be an effective second-tier treatment for symptoms of ADHD, but it has an effect size less than that of stimulants.
Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis
Data from the six available studies of standard release Adderall show it to be efficacious for symptoms of inattention, hyperactivity- impulsivity, and aggression, as well as global ratings.
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis
Current best evidence supports using immediate release methylphenidate as first-line treatment for most adults with ADHD, and key gaps in evidence were academic, occupational, social functioning, cardiovascular toxicity, and longer-term outcomes.
A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
Robust doses of methylphenidate are effective in the treatment of adult ADHD, independent of gender, psychiatric comorbidity with anxiety or moderate depression, or family history of psychiatric disorders.
A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
The effect of low-dose methylphenidate in adult ADHD patients with concomitant substance use disorders is limited, and ADHD symptoms in adults were susceptible to a distinct short-term placebo response.